Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

To investigate whether controlled skin-directed Solius UVB light therapy exposure can exert systemic effects beyond vitamin D synthesis, such as altering gut microbiota composition and function, we first established the efficacy and safety of the Solius UVB light therapy device, and its ability to increase vitamin D levels.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Weanling (3-week-old) female C57BL/6 mice were purchased from Charles River Laboratories (St.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Skin-directed Solius UVB light therapy increases vitamin D levels and alters intestinal microbiome and metabolome homeostasis

Study design awaiting verification · Frontiers in Microbiology · 2026

Original publication title

Skin-directed Solius UVB light therapy increases vitamin D levels and alters intestinal microbiome and metabolome homeostasis

Maira Jimenez-Sanchez; Hyungjun Yang; Ho Pan Sham; Zhiquan Clarence Huang; Jan P. Dutz; Bruce A. Vallance

Copyright © 2026 Jimenez-Sanchez, Yang, Sham, Huang, Dutz and Vallance.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The recent global rise in immune and inflammatory diseases, such as psoriasis and inflammatory bowel diseases, has been linked to Western society-based changes in lifestyle and environment. These include decreased exposure to sunlight in the ultraviolet B (UVB) spectrum, leading to impaired production of 25-hydroxyvitamin D. In addition, many of these diseases are linked to dysbiotic changes in gut microbiota composition and function. Clinical overlap between skin and gut diseases, along with growing evidence for a bidirectional “skin-gut axis,” supports the concept that exposing the skin to UVB light may impact the gastrointestinal tract including the microbiome.

At present, exactly how UVB exposure influences gut microbial and metabolomic profiles and the role that baseline vitamin D status may play in these relationships remains unclear. To test this, we fed mice either a vitamin D sufficient or deficient diet and exposed them to Solius UVB light therapy (targeted peak of 293 nm) either acutely (single exposure) or repeatedly (six exposures) over 14 days. A single exposure modestly increased circulating vitamin D levels, whereas repeated exposures significantly increased levels to that seen in mice fed a vitamin D sufficient diet, and caused skin photoadaptation without histological injury.

Notably, repeated Solius UVB light therapy induced significant changes in the composition of the gut microbiota, coinciding with marked fecal metabolome alterations, particularly in mice fed the vitamin D deficient diet. These fecal metabolic changes included increases in short chain fatty acids, as well as bile acid and tryptophan derivatives. In contrast, serum metabolomic responses were less marked, suggesting that Solius UVB light therapy induction of overt metabolic shifts within the intestinal tract is not merely reflective of systemic responses.

Together, these findings demonstrate that skin-directed Solius UVB light therapy can be delivered safely, to induce significant changes in the composition of the gut microbiota and its associated metabolites, in a manner that depends on repeated exposures and baseline vitamin D status. Further studies exploring the ability of Solius UVB light therapy skin exposure to promote intestinal homeostasis and health are thus warranted.

Authors’ abstract

The recent global rise in immune and inflammatory diseases, such as psoriasis and inflammatory bowel diseases, has been linked to Western society-based changes in lifestyle and environment. These include decreased exposure to sunlight in the ultraviolet B (UVB) spectrum, leading to impaired production of 25-hydroxyvitamin D. In addition, many of these diseases are linked to dysbiotic changes in gut microbiota composition and function. Clinical overlap between skin and gut diseases, along with growing evidence for a bidirectional “skin-gut axis,” supports the concept that exposing the skin to UVB light may impact the gastrointestinal tract including the microbiome.

At present, exactly how UVB exposure influences gut microbial and metabolomic profiles and the role that baseline vitamin D status may play in these relationships remains unclear. To test this, we fed mice either a vitamin D sufficient or deficient diet and exposed them to Solius UVB light therapy (targeted peak of 293 nm) either acutely (single exposure) or repeatedly (six exposures) over 14 days. A single exposure modestly increased circulating vitamin D levels, whereas repeated exposures significantly increased levels to that seen in mice fed a vitamin D sufficient diet, and caused skin photoadaptation without histological injury.

Notably, repeated Solius UVB light therapy induced significant changes in the composition of the gut microbiota, coinciding with marked fecal metabolome alterations, particularly in mice fed the vitamin D deficient diet. These fecal metabolic changes included increases in short chain fatty acids, as well as bile acid and tryptophan derivatives. In contrast, serum metabolomic responses were less marked, suggesting that Solius UVB light therapy induction of overt metabolic shifts within the intestinal tract is not merely reflective of systemic responses.

Together, these findings demonstrate that skin-directed Solius UVB light therapy can be delivered safely, to induce significant changes in the composition of the gut microbiota and its associated metabolites, in a manner that depends on repeated exposures and baseline vitamin D status. Further studies exploring the ability of Solius UVB light therapy skin exposure to promote intestinal homeostasis and health are thus warranted.

Publication and source details

Original title: Skin-directed Solius UVB light therapy increases vitamin D levels and alters intestinal microbiome and metabolome homeostasis

Maira Jimenez-Sanchez; Hyungjun Yang; Ho Pan Sham; Zhiquan Clarence Huang; Jan P. Dutz; Bruce A. Vallance

Frontiers in Microbiology · 2026

* Correspondence: Bruce A. Vallance, bvallance@cw.bc.caCopyright © 2026 Jimenez-Sanchez, Yang, Sham, Huang, Dutz and Vallance.2026Jimenez-Sanchez, Yang, Sham, Huang, Dutz and Vallancehttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by grants from the Canadian Institutes of Health Research (CIHR), Crohn's and the Natural Sciences and Engineering Research Council of Canada (NSERC) awarded to Bruce A. Vallance. Additional support was provided by Solius Inc. Maira Jimenez-Sanchez was supported by a PhD scholarship from SECIHTI (Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Mexico).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-08T15:06:44+00:00

DOI: 10.3389/fmicb.2026.1850035 · PMC13508600